Invivoscribe’s Support to CERo Therapeutics Image: News Hub Medianet Announcement Invivoscribe Inc., a leader in measurable residual disease (MRD) testing and accurate diagnostics, is joining hands with and appreciating CERo Therapeutics Holdings Inc.’s approach to innovative immuno...
Belay Diagnostics Evaluation Received the Green Signal Image Credits: Nature Announcement Belay Diagnostics, a CAP/CLIA Laboratory known for its commercialization and development of molecular diagnostics, mainly focusing on central nervous system (CNS) cancers, has confirmed the analytical vali...
Chugai and Gero Signed a License and Joint Research Agreement Image Credits: BioPharma BoardRoom Announcement Chugia Pharmaceutical Co., Ltd. and Gero PTE.LTD both a Singapore-based biotechnology company, has signed a licensed and joint research agreement to develop and introduce therapies for ...
Celltrion’s New Launch of Medication in the US Image Credits: Chosunbiz Announcement Celltrion USA confirmed that OSENVELT (denosumab-bmwo) and STOBOCLO (denosumab-bmwo), references to XGEVA and PROLIA, are available in the US. Access to these medications will improve and enhance patient ...
AI and Genetics: A New Hope for Pharma Companies Image Credits: Allerin Current Situation The pharmaceutical industry is facing difficulties in gaining the public's trust. The drug reactions often cause adverse effects to health and are not suitable for every individual. The advancement and dev...
Nasal COVID-19 Vaccine Demonstrates Positive Results in Phase 1 Clinical Trial Image Credits: NBC News Findings During the extreme stage of the COVID-19 pandemic, scientists noted that the complications of this infection started to increase severely with the SARS-CoV-2 virus entering the nasal ...
Onco-Innovations and Nucro-techniques Partnership to Elevate Human Trials Image Credits: WIVB Announcement Onco-Innovations Limited has signed an agreement with Nucro-technics Inc. on 3rd July 2025. Through this agreement, Nucro-Technics will organize a vast range of preclinical studies contrib...
Drug Development and Real-world Clinical Needs Establish a New Era in Oncology Image Credits: MEDSIR Concern The United States, till now, has completed 321.4% of phase 2/3 clinical trials. The percentage is less than compared of other regions' clinical trials. The patient recruitment and protoc...
Fresenius Medical Care and CCINSHAE's Strategic Collaboration to Expand Innovative Therapy Image Credits: Fresenius Medical Care Announcement Fresenius Medical Care, a global provider of products and services for patients suffering from renal diseases, will expand high-volume hemodiafiltration ...
Innocare’s Received Approval for a Clinical Trial in China Image Credits: BioWorld Announcement Innocare Pharma, a global biopharmaceutical company known for its advanced treatment for autoimmune diseases and cancer, received approval of an IND Investigational New Drug by the CDE Center f...
